tiprankstipranks
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
US Market

Verona Pharma (VRNA) Income Statement

Compare
718 Followers

Verona Pharma Income Statement

Last quarter (Q3 2024), Verona Pharma's total revenue was $5.62M, an increase of Infinity% from the same quarter last year. In Q3, Verona Pharma's net income was $-42.96M. See Verona Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 458.00K$ 40.00M$ 0.00$ 2.35K
Gross Profit
$ -679.62K$ 112.00K$ 40.00M$ -627.85K$ -509.76K
Operating Expenses
$ 67.15M$ 66.23M$ 97.68M$ 66.01M$ 53.41M
Depreciation and Amortization
$ 679.62K$ 636.00K$ 629.00K$ 627.85K$ 512.11K
EBITDA
$ -52.47M$ -67.29M$ -42.19M$ -47.81M$ -32.17M
Operating Income
$ -67.83M$ -66.12M$ -73.31M$ -74.28M-
Other Income/Expenses
$ 12.62M$ 7.30M$ -1.37M$ 6.78M$ 8.99M
Pretax Income
$ -55.21M$ -68.45M$ -55.59M$ -65.00M-
Net Income
$ -54.37M$ -68.70M$ -55.57M$ -65.15M-
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.09$ -1.04$ -0.94$ -1.98$ -3.18
Diluted EPS
$ -0.09$ -1.04$ -0.94$ -1.98$ -3.18
Weighted Average Shares Outstanding
604.10M 66.13M 59.15M 32.87M 13.17M
Weighted Average Shares Outstanding (Diluted)
634.14M 66.13M 59.15M 32.87M 13.17M
Currency in USD

Verona Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis